Vifor Pharma Management Ltd - Company Profile
Powered by 
All the data and insights you need on Vifor Pharma Management Ltd in one report.
$295
- Save hours of research time and resources with
our up-to-date Vifor Pharma Management Ltd Strategy Report
- Understand Vifor Pharma Management Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Vifor Pharma Management Catalyst Calendar
Proactively evaluate Vifor Pharma Management Ltd’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.
A sample of Vifor Pharma Management Catalyst Calendar data
| Event Date | Event Type | Company Name | Ticker Symbol | Drug Name | Therapy Area | Indication | Source Type |
|---|---|---|---|---|---|---|---|
| 01 Feb 2020 | GDCTWXYZ | Lorem | Lorem | Lorem | WXYZ | Planned | Lorem |
| 01 Jan 2020 | Phase IV Trial Initiation | NHS Greater Glasgow and Clyde; University of Glasgow; Vifor Pharma Management Ltd | VIFN | patiromer sorbitex calcium | Cardiovascular; Metabolic Disorders | Chronic Heart Failure; Congestive Heart Failure (Heart Failure); Edema; Hyperkalemia | Clinical Trial Registry |
| 31 Dec 2019 | Phase II Trial Results | Clinipace Worldwide Inc; Sanifit Therapeutics SA | - | SNF-472 | Cardiovascular; Genito Urinary System And Sex Hormones | Arterial Calcification; Cardiovascular Calcification; Cardiovascular Disease; End-Stage Kidney Disease (End-Stage Renal Disease or ESRD); Vascular Calcification | Company Press Release |
| 01 Dec 2019 | Phase I Trial Initiation | Vifor Pharma Management Ltd | VIFN | INS-3001 | Cardiovascular | Aortic Valve Stenosis; Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD); Vascular Calcification | Company Reports |
Feature
Catalyst Calendar provides forecasted drug development milestones within the Pharma industry including expected timing, expected outcomes and possible financial impacts.
Benefit
Access:
- Trial Events for trials conducted globally by a company, university, institute or CRO: Trial Initiation, Trial Completion, Trial Results
- Regulatory Events related to drug filings with regulatory bodies, approvals and commercial launches. This is covered for the US, EU and Japan
- Intellectual Property Events for patent and exclusivity expiry specific to the US, EU and Japan: Constraining Patent Expiry (US/EU/Japan), Drug Expiry (US/EU/Japan), Commercial Launch (US/EU/Japan)
Value
Proactively evaluate companies and catalyst impacts
Stay ahead of the competition & improve corporate planning
Bolster business development with timely opportunities
Premium databases is part of our industry range of products
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer